In The News

Proton therapy has shown benefit for the treatment of cancers and tumors of the brain, head and neck, lung, breast, lymphoma, liver and prostate. Dr. Andrew Lee of Texas Center for Proton Therapy says that proton therapy not only treats tumors but minimizes exposure to surrounding normal tissues, delivering targeted radiation to tumors with extraordinary precision. Dr. Lee says that TCPT combines the most advanced technology available with a world-class team of expert health care providers, physicians, and physicists.

Dr. Sheila Haffar, medical oncologist at Texas Oncology-Mesquite discusses the importance of having a community-based cancer research program that offers leading-edge clinical trials to patients near their homes and loved ones, requiring no more travel or disruption than an afternoon shopping trip. Gone are the days of traveling hundreds of miles to receive the best, most innovative cancer treatment, thanks to Texas Oncology. 

Dr. Sylvia Jaramillo, a medical oncologist at Texas Oncology–Austin North, visited Keilah Radio’s morning show to discuss skin cancer detection, symptoms, prevention and treatment with the station’s Spanish speaking-audience. Dr. Jaramillo discusses both melanoma and non-melanoma skin cancers, the importance of self examinations and elaborated on her experience treating skin cancer in the Austin community.

Texas Oncology-Tyler breast cancer patient Wendy Freden went viral for celebrating the end of chemotherapy by punching the cancer bell instead of ringing it. Wendy highlights what this moment meant to her and her oncologist, Dr. Sasha Vukelja, discusses the importance of self-breast exams to increase early detection.

After four rounds of chemo and a double mastectomy, Texas Oncology-Tyler patient Wendy Freden knew she didn't just want to ring the bell that signifies the end of treatment, she wanted to "punch it off the wall." Videos and photos capture the celebratory moment perfectly. 

Local Tyler Junior College football coach Danny Palmer shares his experience using a new, FDA-approved cancer drug that's helping treat his chronic lymphocytic leukemia. Meriam Eakin, a retired school librarian in Tyler, has a similar success story using Imbruvica, being part of its clinical trial at Texas Oncology-Tyler led by Dr. Donald Richards, before the drug became FDA approved.

When it comes to a cancer diagnosis, understanding the way forward means knowing your options. It may also mean preparing for your future. Dr. Sandhya Bejjanki of Texas Oncology-Cleburne shares the benefits of palliative care and the importance of having conversations to prepare for your future healthcare decisions. 

Dr. Asad Dean and Dr. Stephen Richey of Texas Oncology–Fort Worth 12th Ave. discuss risk factors, signs and symptoms as well as prevention methods for both renal and bladder cancer with the hosts and listeners of DocTalk Live, a radio show dedicated to educating the DFW area on all aspects of healthcare.

Almost two years after being diagnosed with stage IV metastatic melanoma and given 4-6 months to live, Philip Durst calls himself the “luckiest cancer victim alive.” At the recommendation of Dr. Jeff Yorio, medical oncologist at Texas Oncology–Austin Central, Durst joined a clinical trial combining two immunotherapy drugs that had not previously been approved for use together – allowing him to be present and healthy for the birth of his granddaughter. Today, he has no metastatic activity.

Texas Oncology's Dr. Tobenna Nwizu shares highlights from this year’s ASCO conference and how innovations and findings are changing how cancer is treated.